Table 1.
Medical and demographic characteristics of 30 evaluable patients.
| Total number of evaluable patients | 30 | |
|---|---|---|
| Age, median (range) | 63(44–78) | |
| Characteristic | N | % |
| Gender | ||
| Male | 18 | 60 |
| Female | 12 | 40 |
| Ethnicity | ||
| Caucasian | 23 | 77 |
| African American | 6 | 20 |
| Hispanic | 1 | 3 |
| Clinical stage | ||
| IB | 2 | 7 |
| IIA | 1 | 3 |
| IIB | 11 | 37 |
| IIIA | 13 | 43 |
| IIIB | 3 | 10 |
| Histology | ||
| Adenocarcinoma | 16 | 53 |
| Squamous cell carcinoma | 7 | 23 |
| Other | 7 | 23 |
| Neoadjuvant chemotherapy | ||
| Cisplatin | 11 | 37 |
| + Taxane | 9 | |
| + Other | 2 | |
| <3 cycles | 5 | |
| ≥3 cycles | 6 | |
| Carboplatin | 19 | 63 |
| + Taxane | 17 | |
| + Other | 2 | |
| <3 cycles | 8 | |
| ≥3 cycles | 11 | |
| Smoking status | ||
| Current smoker | 10 | 33 |
| Former smoker | 10 | 33 |
| Never smoker | 5 | 17 |
| Undocumented | 5 | 17 |
| Tumor response by RECIST | ||
| Stable disease | 22 | 73 |
| Partial response | 8 | 27 |
| Tobacco pack years | 32 (0–145) | |
| Time lapse from last chemotherapy (days) | 37 (22–71) | |
Abbreviations: RECIST= Response Evaluation Criteria in Solid Tumors